A common blood test can flag early Alzheimer's disease patients who are four times more likely to experience rapid brain ...

Verve Therapeutics, Inc. (NASDAQ:VERV) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. Eli Lilly and ...

Shares in Verve Therapeutics ( VERV -0.54%) soared 80.5% this week on the news of an agreement for Eli Lilly ( LLY -2.54%) to ...

Eli Lilly LLY signed a definitive agreement to acquire Verve Therapeutics VERV for a total deal value of nearly $1.3 billion.

The acquisition aligns with Eli Lilly’s broader diversification strategy beyond its core diabetes and obesity treatment ...

Drugmaker Eli Lilly plans to buy Verve Therapeutics, a gene-editing startup, for about $1 billion upfront. The deal gives ...

Eli Lilly has announced that it will be acquiring Verve Therapeutics in a deal worth approximately $1.3bn, marking a ...

Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...

Deal would add a potential treatment for cardiovascular disease to Eli Lilly’s portfolio.

米医薬品大手イーライリリーは、遺伝子編集技術の米新興企業バーブ・セラピューティクスを最大１３億ドルで買収し、心血管疾患に対する新たな治療法開発を加速させる方針だ。両社が１７日発表した。

日本製鉄による米鉄鋼大手ＵＳスチールの買収が１８日、完了した。両社が日本時間同日発表した。経済安全保障への影響を懸念する米政府が、ＵＳスチールの黄金株を保有するなどして重要な決定事項に関与する。

Solar stocks tumbled after Senate Republicans maintained a full phase-out of [solar and wind-energy tax credits]( ...